US SEC Filings Daily Market Digest — September 29, 2026

29-09-2026

Pine Tree Acquisition Corp. (PAXG) filed an S-1/A registration statement on September 29, 2026, for an IPO of up to 11,500,000 units. The offering structure includes 10,000,000 public units, 140,000 private placement units, and 400,000 representative shares, with founder shares representing approximately 43% of shares sold. The company has no operating history and is a blank-check SPAC seeking a business combination, with founder shares purchased for $25,000 (approximately $0.005 per share) and subject to a one-year lock-up post-combination.

• · Each right entitles holder to receive 3/4 of one Class A ordinary share upon business combination; fractional shares not issued, requiring multiples of four rights.
• · Founder shares have anti-dilution protection to maintain ~43% ownership of post-offering shares, with conversion ratio adjusted if additional equity-linked securities are issued.
• · Representative shares (400,000) are deemed compensation by FINRA and subject to 180-day lock-up from commencement of sales.
• · Holders of Class B founder shares have exclusive voting rights on director appointment/removal and continuing the company outside Cayman Islands prior to business combination.
• · If no business combination completed within required time, rights expire worthless and receive no trust account proceeds.

29-09-2026

GEN Restaurant Group, Inc. entered into a Common Stock Purchase Agreement with Roth Principal Investments, LLC, securing the right to sell up to $25,000,000 of newly issued Class A common stock over a 36-month period at the company's sole discretion. The agreement provides flexible financing through various purchase mechanisms (Market Open, Intraday, Pre-Market, Post-Market) at discounts of 3% to 5% to VWAP, but is subject to an Exchange Cap of 6,776,399 shares (19.99% of outstanding shares) unless stockholder approval is obtained or a minimum price threshold is met. While this gives the company a potential source of capital without immediate dilution, the actual use of the facility depends on market conditions and stock price, and the discounts could result in dilution if shares are sold.

• · The Purchase Agreement has a 36-month term beginning on the Effective Date (when the Registration Statement is declared effective by the SEC).
• · The company is under no obligation to sell any securities; sales are solely at its option.
• · Purchases are subject to a minimum price threshold (closing sale price on the prior trading day not less than a specified threshold).
• · The Exchange Cap of 6,776,399 shares may be exceeded if the average price per share paid by Roth equals or exceeds the Base Price (Minimum Price + $0.0738).
• · Roth Principal Investments cannot beneficially own more than 4.99% of outstanding Class A common stock as a result of purchases.
• · No upper limit on the price per share Roth could be obligated to pay.
• · The company must file a Registration Statement with the SEC for the resale of shares by Roth.

29-09-2026

TruGolf Holdings, Inc. filed an 8-K on September 29, 2026, reporting material modifications to security holder rights (Item 3.03) and amendments to its articles of incorporation or bylaws (Item 5.03), along with other events (Item 8.01) and exhibits (Item 9.01). The filing does not disclose specific financial metrics, transaction values, or forward-looking guidance, limiting quantitative analysis. The event appears to be a mandatory disclosure of corporate governance changes, but the lack of detail on the nature of the amendments or their financial impact makes the overall sentiment neutral.

• · Filed on September 29, 2026, with AccNo: 0001493152-26-044920 and size 1 MB.
• · Multi-item filing covering Items 3.03, 5.03, 8.01, and 9.01.
• · Sector not specified in the filing summary.
• · No specific amendments, rights modifications, or other events described in the provided summary.

29-09-2026

International Finance Corporation (IFC) and its affiliated funds filed Amendment No. 6 to Schedule 13D, disclosing that the IFC African, Latin American and Caribbean Fund LP (ALAC) sold 860,649 shares of Lesaka Technologies common stock between June 22 and September 28, 2026, for aggregate gross proceeds of approximately $4.09 million. Following these sales, IFC's aggregate beneficial ownership dropped to 3.81% (3,271,862 shares), while ALAC holds 1.16% (995,614 shares) and the IFC Financial Institutions Growth Fund holds 3.85% (3,302,551 shares). The sales occurred at prices ranging from $4.20 to $5.025 per share, with the most recent transactions in late September 2026 at the lower end of the range (around $4.20-$4.30), indicating a declining trend in the stock price during the selling period.

• · The filing is an amendment to a Schedule 13D originally filed on June 1, 2016.
• · IFC's aggregate ownership is based on 85,824,094 shares outstanding as of September 9, 2026.
• · ALAC's sales occurred over 34 separate trading days with prices ranging from $4.20 to $5.025 per share.
• · The weighted average sale price declined from ~$4.79 in late June to ~$4.25 in late September 2026.
• · FIG's ownership remained unchanged at 3,302,551 shares (3.85%).

29-09-2026

PMGC Holdings Inc. (formerly Elevai Labs Inc.) has become the sole member of NorthStrive Sponsor I LLC, the sponsor of SPAC NorthStrive Acquisition Corp I., effective retroactively to April 24, 2026. Through this arrangement, PMGC now holds voting and dispositive power over 2,728,070 Class A ordinary shares of the SPAC (a 21.43% stake), consisting of shares underlying Class B shares and private placement units. The filing indicates the Reporting Persons are in discussions with third parties regarding potential strategic transactions, including a possible merger or business combination, but no definitive agreements exist.

• · PMGC Holdings Inc. is a Nevada corporation formerly named Elevai Labs Inc. and Reactive Medical Labs Inc., now a diversified holding company.
• · NorthStrive Sponsor I LLC is a Delaware limited liability company formed on April 23, 2026.
• · The SPAC's IPO was consummated on August 19, 2026.
• · Georgiy Kovalyov, a Canadian citizen and CPA, is the Manager of the Sponsor but holds 0% beneficial ownership.
• · No Reporting Person has been convicted in a criminal proceeding or subject to securities-related civil judgments in the last five years.
• · No transactions in the reported securities were effected within the past 60 days.
• · The Sponsor purchased its shares using working capital funds; PMGC used working capital for its membership interest.

29-09-2026

Delek US Holdings announced a proposed private offering of $400.0 million aggregate principal amount of convertible senior notes due 2031, with an option for initial purchasers to buy up to an additional $60.0 million. Proceeds will be used to partially repay amounts outstanding under the Term Loan Credit Facility, fund capped call transactions to offset potential dilution, and for general corporate purposes. The offering is opportunistic and enhances financial flexibility, but it increases leverage and potential dilution, with the notes being senior unsecured obligations.

• · Notes mature on November 1, 2031, unless earlier converted, redeemed or repurchased.
• · Notes are convertible prior to August 1, 2031 only upon satisfaction of certain conditions; thereafter convertible at any time until the second scheduled trading day before maturity.
• · Company may not redeem notes prior to November 6, 2029, except for a cleanup redemption.
• · Notes will be guaranteed by subsidiaries that guarantee the Term Loan Credit Facility or Revolving Credit Facility.
• · Offering is private, limited to qualified institutional buyers under Rule 144A.
• · Notes and related guarantees are unregistered and may not be offered or sold in the U.S. without registration or exemption.
• · Option counterparties may engage in derivative transactions that could affect the market price of common stock and notes.
• · Refining assets include refineries in Tyler and Big Spring, Texas, El Dorado, Arkansas, and Krotz Springs, Louisiana.

29-09-2026

Essential Utilities, Inc. provided an integration planning update regarding its pending merger with American Water, reiterating the expected closing by the end of Q1 2027. The update covers future organizational role selections, Day 1 policy changes (including a ban on cell phone use while driving and phase-out of personal-use company vehicles by December 31, 2028), and a side-by-side Delegation of Authority framework. While the merger remains on track, the communication highlights ongoing integration challenges and the need for careful transition management.

• · Employees will not be permitted to use cell phones while driving on the job (including hands-free) starting Day 1.
• · Personal-use company vehicle program will be phased out and end on December 31, 2028.
• · Delegation of Authority (DoA) frameworks will operate side-by-side on Day 1, with targeted updates to Essential's thresholds.
• · A limited number of roles will move to the Service Company on Day 1 due to immediate business need or regulatory requirements.
• · Next role selection process expected in late October and into early November 2026.
• · Merger expected to close by end of Q1 2027.

29-09-2026

Hennessy Capital Investment Corp. VII (HVII) filed an 8-K on September 29, 2026, disclosing the unaudited financial statements of ONE Nuclear Energy LLC, the target in a planned $1.0 billion all-stock business combination. ONE Nuclear, a development-stage IPP focused on behind-the-meter microgrids and SMRs for AI data centers, reported a net loss of $1,802,923 for the six months ended June 30, 2026, and had only $2,588 in cash. The company's auditors have expressed substantial doubt about its ability to continue as a going concern, highlighting significant financial risk despite the proposed merger.

• · ONE Nuclear was formed on February 10, 2025, and has no revenue to date.
• · The company's working capital deficit was $2,736,205 as of June 30, 2026.
• · Equity-based compensation expense was $16,801 for the six months ended June 30, 2026.
• · The company had $60,000 in accrued commitment fees to HVII and $22,352 to B. Riley Capital as of June 30, 2026.
• · The comparative period (Feb 10, 2025 through June 30, 2025) is less than five months and not directly comparable to the 2026 periods.

29-09-2026

Conifer Management, L.L.C. filed Amendment No. 3 to its Schedule 13D, disclosing beneficial ownership of 1,840,698 shares of Group 1 Automotive Inc. common stock, representing 15.4% of outstanding shares. Since the prior amendment on September 22, 2026, Conifer purchased an additional 328,408 shares for approximately $80.5 million through open-market transactions for accounts including Acacia Partners, L.P. and Acacia Conservation Fund, LP. The purchases were made at prices ranging from $235.11 to $253.85 per share, with the most recent transactions on September 29, 2026, executed at lower prices (as low as $235.11), indicating a potential decline in the stock price during the accumulation period.

• · The filing is Amendment No. 3 to the Schedule 13D, with prior amendments filed on August 20, 2026, September 8, 2026, and September 22, 2026.
• · Conifer Management has sole voting and dispositive power over all 1,840,698 shares.
• · Funds for purchases came from general working capital of commingled investment vehicles, which may include margin account borrowings; shares in margin accounts are pledged as collateral.
• · The volume-weighted average price per share for the largest lot on 9/29/2026 (28,791 shares) was $240.87, with a low of $240.33 and high of $241.32.
• · The lowest price paid in the reported period was $235.11 per share on 9/29/2026.

29-09-2026

29-09-2026

United Microelectronics Corporation (UMC) filed a Form 6-K with the SEC on September 29, 2026, as a routine foreign issuer report under the Securities Exchange Act of 1934. The filing was signed by CFO Chitung Liu and includes an exhibit (Exhibit 99.1) but contains no specific financial data, operational updates, or material disclosures.

29-09-2026

ChipMOS Technologies reported strong financial results for August 2026 and Q2 2026, with revenue growing 33.3% YoY in August and 28.7% YoY in the quarter. Net profit attributable to owners surged 117.6% YoY in August and 267.4% YoY in Q2, driven by robust operational performance. No negative or flat metrics were present in the filing.

• · Trailing four quarters (2025Q3-2026Q2) revenue was NT$26,983M, net profit before tax NT$2,675M, and profit attributable to owners NT$2,248M.
• · EPS for the trailing four quarters was NT$3.21.

29-09-2026

Westlake Corp announced plans to cease operations at its PVC production plant in Cologne, Germany, by Q1 2027, with expected total pre-tax charges of approximately $205 million. The closure will reduce the workforce by about 120 employees, but the company will continue supplying customers from other facilities, including the recently acquired Wilhelmshaven site, to benefit from lower costs. The company also issued a press release providing an update on Q3 2026 financial performance, though specific financial results were not disclosed in this filing.

• · Cessation of operations at the Cologne facility is expected in Q1 2027.
• · Consultations with local works councils initiated on September 29, 2026.
• · Remaining charges (approximately $130 million) expected to be recognized during 2027.
• · Certain cash outflows are expected over several years through completion of the closure.
• · The company will continue supplying customers from other chlorovinyl facilities, including the recently acquired Wilhelmshaven site.
• · The press release furnished as Exhibit 99.1 provides an update on Q3 2026 financial performance, but specific figures were not included in this filing.

29-09-2026

Aquestive Therapeutics appointed Rich Daly to its Board of Directors, effective October 14, 2026. Mr. Daly brings over 30 years of life sciences leadership, including commercial launch expertise at AstraZeneca, Takeda, and Catalyst, which the company views as valuable as it prepares for the potential FDA approval and launch of Anaphylm. The board will now consist of eight directors, seven of whom are independent.

• · Rich Daly currently serves as President of Global Rare Disease at Angelini Pharma S.p.A. following Angelini's acquisition of Catalyst Pharmaceuticals, where he was President and CEO.
• · Mr. Daly previously served as Chairman and CEO of Neuralstem, COO of BeyondSpring Pharmaceuticals, COO and board member of Seed Therapeutics, and President of CARsgen Therapeutics Holdings Limited.
• · He has served on the boards of Catalyst Pharmaceuticals, Opiant Pharmaceuticals, Neuralstem, and Synergy Pharmaceuticals, where he chaired the Nominating and Governance Committee.
• · Aquestive is the exclusive manufacturer of four commercialized products marketed by its licensees across six continents.
• · The AdrenaVerse platform contains a library of more than 20 epinephrine prodrugs.

29-09-2026

One & One Green Technologies reported a 18.7% YoY revenue increase to $33.4M for H1 2026, with net income rising 17.4% to $4.5M. However, operating income declined 12.6% YoY to $5.0M due to a sharp increase in general and administrative expenses, and the company generated negative operating cash flow of -$9.9M, compared to -$1.7M in the prior period. Total assets grew 30.5% to $73.1M, supported by a $11.8M equity issuance, but the foreign currency translation loss widened to -$1.5M.

• · Gross profit margin remained nearly flat: 21.7% in H1 2026 vs 25.3% in H1 2025 (slight decline).
• · Selling and marketing expenses decreased 12.1% YoY to $219,295.
• · Interest income surged to $29,114 from $307, while other income swung to $1.1M from a -$0.8M loss.
• · Income tax expense increased 51.3% YoY to $1.6M.
• · Earnings per share (basic and diluted) improved to $0.08 from $0.07.
• · Total comprehensive income fell 33.2% YoY to $3.0M due to a $1.5M foreign currency translation loss.
• · Shareholders' equity increased 35.5% to $56.7M, driven by the equity issuance and retained earnings.
• · The company issued 1,733,333 Class A shares and warrants, raising $11.8M net.
• · Operating cash flow was deeply negative at -$9.9M, primarily due to large increases in accounts receivable ($7.4M) and inventories ($10.5M).
• · Capital expenditures were $0.75M in H1 2026 vs nil in H1 2025.

29-09-2026

Stewards, Inc. (SWRD) filed an 8-K on September 29, 2026, indicating a material agreement entry related to the acquisition of Envy Development PB, LLC, which owns a 214-unit apartment complex in Pompano Beach, Florida. The audited financial statement for the year ended December 31, 2025, shows total revenue of $4,904,596 and revenues in excess of certain operating expenses of $401,447, resulting in a thin margin of approximately 8.2%. The filing includes an emphasis-of-matter paragraph noting the financial statement was prepared solely for SEC compliance and is not a complete presentation of the company's revenues and expenses.

• · The property is a 214-unit residential community located in Pompano Beach, Florida.
• · The financial statement was prepared solely for SEC Rule 3-14 compliance and excludes management fees, depreciation, amortization, and interest.
• · No single tenant comprised over 10% of total revenue in 2025.
• · The company received a $202,030 federal income tax refund subsequent to year-end from a successful property tax challenge.
• · Minimum future lease rentals total $4,479,997, with $4,227,152 due in 2026 and only $252,845 thereafter, indicating most leases expire in 2026.

29-09-2026

ING Groep N.V. filed a Form 6-K with the SEC on September 29, 2026, covering the month of September 2026, and incorporated a press release dated September 29, 2026, as Exhibit 99.1. The filing is a routine foreign private issuer report and contains no financial results or operational data.

• · Filing date: September 29, 2026
• · Commission File Number: 001-14642
• · Registrant address: Bijlmerdreef 106, 1102 CT Amsterdam, The Netherlands
• · Exhibit 99.1: Press release dated September 29, 2026

29-09-2026

Equinor ASA disclosed its daily share buy-back transactions on the Oslo Stock Exchange (OSE) for the week of September 21-25, 2026. The company repurchased a total of 701,262 shares during the week at a weighted average price of NOK 405.97 per share, for a total weekly value of approximately NOK 284.7 million. This brings the accumulated buy-backs under the current tranche to 6,269,053 shares at a total cost of approximately NOK 2.47 billion.

• · All transactions occurred exclusively on the Oslo Stock Exchange (OSE); no activity was reported on CEUX or TQEX.
• · The daily weighted average share price fluctuated between NOK 397.31 and NOK 415.54 during the week.
• · The highest daily volume was 144,493 shares on September 22, while the lowest was 135,769 shares on September 24.
• · Previously disclosed buy-backs under the tranche totaled 5,567,791 shares at a weighted average price of NOK 393.38.

29-09-2026

Liberty Star Uranium & Metals Corp. entered into a Securities Purchase Agreement with Monroe Street Capital Partners LP on September 21, 2026, issuing a convertible promissory note with a principal amount of $95,700. The note carries an 8% interest rate, matures in one year, and includes a 10% original issue discount. This financing provides the company with approximately $86,130 in net proceeds after the OID.

• · The note matures in one year from the date of the agreement (September 21, 2026).
• · The outstanding principal and accrued interest are convertible into shares of the company's common stock.
• · The filing includes exhibits: Convertible Promissory Note (Exhibit 3.89) and Securities Purchase Agreement (Exhibit 3.90).

29-09-2026

HUTCHMED announced the submission of a US New Drug Application (NDA) for ORPATHYS® (savolitinib) in combination with TAGRISSO® (osimertinib) for the treatment of MET-driven EGFR-mutated lung cancer. This regulatory milestone could expand the company's oncology portfolio and address an unmet medical need. However, the filing provides no financial details, and the outcome of the NDA review remains uncertain.

• · The NDA submission is for MET-driven EGFR-mutated lung cancer, a specific patient population.
• · The filing is a Form 6-K for the month of September 2026, with the press release as Exhibit 99.1.
• · The company's principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.

29-09-2026

Sumitomo Mitsui Financial Group (SMFG) reported strong financial results for FY2026 (year ended March 2026), with operating revenue rising 11.4% YoY to ¥551,827 million and net profit increasing 15.9% to ¥88,933 million. The filing also disclosed the establishment of SMBC Nikko Securities Holdings Establishment Preparatory Company, Inc., a wholly owned subsidiary, which is expected to transition to an intermediate holding company structure on October 1, 2026.

• · Net profit per share for FY2026 was ¥444,663.86, up from ¥383,564.51 in FY2025.
• · The SMBC Nikko Securities Holdings Establishment Preparatory Company was established on April 1, 2005, and is expected to transition to an intermediate holding company structure on October 1, 2026.
• · The Preparatory Company is 100% owned by SMFG and has a capital of ¥10 million.

29-09-2026

Ituran Location & Control Ltd. filed its annual report for the year ended December 31, 2025, on Form 20-F with the U.S. SEC. The report includes audited financial statements and the management discussion and analysis. Shareholders can request a free hard copy of the audited financial statements.

• · Registrant files annual reports under Form 20-F (not 40-F).
• · The 6-K is submitted in paper? No (checked as 'No').
• · The filing confirms the annual report for fiscal year ended December 31, 2025, has been furnished to the SEC.

29-09-2026

On September 25, 2026, Ever Orient International Ltd., Data Bliss Ltd., and Mr. PENG Yongdong sold 5,344,661 ADSs (representing 16,033,983 Class A ordinary shares) of KE Holdings Inc. (BEKE). This disposal reduced the reporting persons' beneficial ownership below 5% of the total outstanding ordinary shares, from a prior 4.7% to below the 5% threshold.

• · The filing is an Amendment No. 1 to a Schedule 13D originally filed on May 30, 2024.
• · The reporting persons previously held 62,824,251 Class A ordinary shares and 94,082,291 Class B ordinary shares.
• · The reporting persons represented that except for the ongoing conversion of Class B ordinary shares to Class A, no other changes occurred from the prior statement.
• · The beneficial ownership calculation treats Class B ordinary shares as converted into Class A for percentage calculation purposes only.

29-09-2026

IperionX Limited filed its Annual Report on Form 6-K with the SEC on September 29, 2026, covering the fiscal year ended June 30, 2026. The filing, signed by CFO Marcela Castro, provides the company's audited financial statements and management discussion for the period. No specific financial figures or operational metrics were disclosed in the filing cover page, limiting quantitative analysis.

• · Filing date: September 29, 2026
• · Commission File Number: 001-41338
• · Principal executive offices: 1092 Confroy Drive, South Boston, Virginia
• · Registrant files annual reports under Form 20-F
• · Exhibit 99.1 contains the Annual Report

29-09-2026

Quartzsea Acquisition Corp is seeking shareholder approval to extend its business combination deadline from October 19, 2026 to February 19, 2027, with up to four one-month extensions, each requiring a monthly deposit into the trust account. As of September 22, 2026, the trust holds approximately $74.9 million, and the estimated redemption price is $10.84 per share, while the closing share price was $10.64. If the extension is not approved, the company will liquidate and redeem 100% of public shares. The board recommends voting 'FOR' all proposals.

• · Special Meeting to be held virtually on October 13, 2026 at 4:00 PM Eastern Time.
• · Redemption deadline is October 8, 2026 (two business days before the meeting).
• · Record date for voting is September 22, 2026.
• · If extension not approved, company will cease operations and liquidate by October 19, 2026.
• · Sponsor has agreed not to seek reimbursement from trust account for dissolution expenses.
• · Board retains discretion to abandon proposals even if approved.
• · Shareholders can redeem regardless of how they vote or whether they vote.
• · Proxy materials available at https://www.cstproxy.com/quartzsea/ext2026.

29-09-2026

WeShop Holdings Ltd filed an F-1 registration statement with the SEC for its initial public offering, outlining plans to expand into the U.S. market and raise capital through a committed equity facility with Roth Principal Investments. As of September 24, 2026, the company has awarded approximately 1.16 million WePoints to users (virtually all in the UK) but none have been redeemed for Class A ordinary shares. The filing highlights significant risks, including the need for substantial additional financing to continue as a going concern and reliance on a limited number of affiliate network partners.

• · The company's Pilot ran from July 2022 to November 2024 in the United Kingdom.
• · Shareback Rates are expected to generally fall within 40% to 80% of the commission received from affiliate networks.
• · WeShop holds registered trademarks in the UK, EU, US, and selected international territories for key brands.
• · The filing includes a 'going concern' risk and states the company requires substantial additional financing to support growth.
• · Forward-looking statements include risks related to competition, management of growth, and potential fluctuations in operating results.

29-09-2026

Evotec SE filed a Form 6-K with the SEC on September 29, 2026, announcing a transition in its Chief Scientific Officer role via a press release attached as Exhibit 99.1. The filing provides no financial details or performance metrics, focusing solely on the executive leadership change.

• · The press release announcing the CSO transition was submitted as Exhibit 99.1 to the Form 6-K.
• · The filing was signed by CEO Christian Wojczewski on September 29, 2026.

29-09-2026

Uranium Energy Corp reported fiscal 2026 results, highlighting a transformational year as it became a multi-mine U.S. uranium producer. Fourth quarter production surged 157% QoQ to 82,744 pounds, with total cost per pound down 33% to $36.54, while the unhedged sales strategy delivered a peer-leading realized price of $93.13 per pound. However, full-year production of 229,294 pounds remains modest relative to industry scale, and the company continues to hold most inventory rather than monetizing it, reflecting a strategic bet on further market tightening.

• · UEC has no debt and $753M in liquid assets, including $495M cash.
• · Full-year production of 229,294 pounds is modest; cumulative production since commissioning is 359,260 pounds.
• · UEC sold only 400,000 pounds from inventory in fiscal 2026, holding 1,256,000 pounds in inventory plus 359,260 pounds in-process.
• · Burke Hollow produced 17,352 pounds in its first full quarter, limited to 126 wells in a small section of the first production area.
• · Christensen Ranch produced 65,392 pounds in Q4, with 4 new header houses approved for startup on Sept 28, 2026.
• · Ludeman wellfield construction is underway; satellite ion-exchange plant engineering advanced with long lead-time equipment procured.
• · Sweetwater EA expected March 2027, Plan of Operations approval expected May 2027.
• · Roughrider PFS is progressing with 36,000 meters of core drilling completed.
• · UR&C Class IV cost estimate expected by mid-2027; license application preparation begun.
• · NNSA RFI outlines need for 4 million pounds per year of unobligated U.S.-origin uranium with deliveries as soon as 2030.
• · U.S. Army Janus Program plans more than 20 microreactors requiring unobligated U.S.-origin uranium.
• · UEC had 17 drill rigs in Powder River Basin (up from 12) and 21 in South Texas (up from 8) at year-end.

29-09-2026

Westin Acquisition Corp filed its Form 10-K for the fiscal year ended June 30, 2026, reporting a net income of $890,446 compared to a net loss of $9,475 in the prior period (June 3, 2025 inception through June 30, 2025). The company held $58.88 million in trust as of June 30, 2026, with total assets of $59.20 million, but also reported that accretion of redeemable shares to redemption value resulted in a net loss including accretion of $3.92 million. Operating cash flow was negative ($330,991), and the company remains a blank-check entity seeking an initial business combination, with no target identified and ongoing risks around liquidity and deal completion.

• · Total operating expenses for fiscal 2026 were $490,333, consisting of $478,565 in administrative fees and $11,768 in formation costs.
• · Income earned on marketable securities held in trust was $1,380,779 for fiscal 2026.
• · Deferred offering costs of $200,000 were recorded as of June 30, 2025 (no assets in trust at that date).
• · Net cash provided by financing activities was $58,150,000, driven by public offering proceeds and private placement.
• · Weighted average redeemable ordinary shares outstanding: 3,733,562; basic/diluted EPS on redeemable shares: $0.63.
• · Weighted average non-redeemable ordinary shares outstanding: 2,202,425; basic/diluted loss per share on non-redeemable shares: ($0.66).

29-09-2026

Singularity Future Technology Ltd. (SGLY) filed a Form NT 10-K late-filing notice on September 29, 2026, indicating it could not file its Annual Report on Form 10-K for the fiscal year ended June 30, 2026 by the September 28, 2026 deadline. The delay is attributed to the company's inability to finalize financial statements and disclosures without unreasonable effort or expense. The company expects to file the Annual Report by October 13, 2026, the fifteenth calendar day after the prescribed due date, and has confirmed that no significant change in results of operations is anticipated.

• · Filing deadline was September 28, 2026; extension filed under Rule 12b-25.
• · Anticipated filing date for the Annual Report is October 13, 2026 (15th calendar day after due date).
• · Registrant confirmed all other required periodic reports for the preceding 12 months have been filed.
• · No significant change in results of operations is anticipated compared to the prior fiscal year.
• · Contact person: Jia Yang, CEO, (702) 849-4548.

29-09-2026

TurnOnGreen, Inc. filed an 8-K on September 29, 2026, disclosing the adoption of new Bylaws effective September 25, 2026. The Bylaws govern corporate governance, including shareholder meetings, director powers, officer roles, and indemnification provisions. The filing is a routine governance update with no financial impact disclosed.

• · The Bylaws were adopted by the Board of Directors effective September 25, 2026.
• · Shareholders holding more than 20% of voting power can call special meetings.
• · Shareholders do not have cumulative voting rights for director elections.
• · The Bylaws include provisions for indemnification of directors and officers.
• · The Bylaws specify a forum selection clause for shareholder disputes.

29-09-2026

Nova Minerals Corp filed a Form NT 10-K on September 29, 2026, indicating it will be unable to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2026 by the prescribed due date. The delay is attributed to the need for additional time to compile, review, and finalize financial statement data, disclosures, and accounting policies following the company's redomicile to the U.S. in June 2026. The company expects to file the report within the 15-day grace period provided by Rule 12b-25 and does not anticipate any significant change in results of operations from the prior fiscal year.

• · The filing is for the fiscal year ended June 30, 2026.
• · The company redomiciled to the U.S. in June 2026, making this its inaugural period filing as a U.S. entity.
• · The company has filed all other periodic reports required under the Exchange Act during the preceding 12 months.
• · The company does not anticipate any significant change in results of operations from the prior fiscal year.
• · The notification was signed by CFO Ashlie Thorburn on September 28, 2026.

29-09-2026

Bakhu Holdings reported a net loss of $(483,981) for the three months ended April 30, 2025, a significant improvement from a net loss of $(906,837) in the prior-year period, driven by lower operating expenses. However, the company had no revenue, cash and cash equivalents fell sharply to $2,041 from $25,461, and total liabilities increased to $11,796,135, reflecting continued financial distress.

• · Net cash used in operating activities improved to $(40,676) for the nine months ended April 30, 2025, from $(1,065,382) in the prior-year period.
• · Stock-based compensation decreased to $1,073,292 for the nine months ended April 30, 2025, from $1,256,951 in the prior-year period.
• · Interest expense increased to $324,666 for the nine months ended April 30, 2025, from $229,555 in the prior-year period.
• · The company had no revenue in either period.
• · Total stockholders' deficit widened to $(11,794,094) at April 30, 2025, from $(11,011,550) at July 31, 2024.
• · Options outstanding decreased by 300,000 due to expiration, from 9,058,085 to 8,758,085.

29-09-2026

Summit Therapeutics announced a $2.0 billion strategic equity investment from AstraZeneca in convertible preferred shares, priced at $18.36 per common share (a premium to the closing price), alongside a clinical trial collaboration to evaluate ivonescimab with AstraZeneca's ADC sonesitatug vedotin in gastrointestinal cancers and a non-binding MOU for broader ADC combinations. The investment and collaboration validate ivonescimab's potential, but the MOU is non-binding with no assurance of fruition, and ivonescimab remains unapproved in Summit's license territories. Summit's Phase III program shows positive readouts across five trials, yet the company faces regulatory and clinical execution risks.

• · Ivonescimab is not approved by any regulatory authority in Summit's license territories, including the US and Europe.
• · The MOU for the broader clinical trial collaboration is non-binding, with no assurances of fruition.
• · AstraZeneca's CLARITY-Gastric01 trial showed statistically significant OS improvement in 2nd/later-line Claudin18.2-positive advanced gastric cancer; results to be presented at ESMO 2026.
• · HARMONi-GI1 (Akeso-sponsored) showed statistically significant OS benefit in advanced BTC; HARMONi-GI3 is a Phase III trial in first-line metastatic CRC.
• · HARMONi-GU1 is a Phase II/III study in urothelial carcinoma with global site activations planned by Q4 2026.
• · Summit's BLA for ivonescimab was accepted by the FDA with a PDUFA date of November 14, 2026.
• · Ivonescimab has a half-life of 6-7 days after first dose, increasing to ~10 days at steady state.
• · Akeso reported positive OS benefits in HARMONi-A, HARMONi-2, HARMONi-6 (NSCLC) and HARMONi-GI1 (BTC) in China.

29-09-2026

Futurewave Acquisition Corp (FWAC) entered into a definitive merger agreement to acquire Olympian Group Inc. in a transaction valuing the company at $400 million. The deal will be effected through a reincorporation merger and an acquisition merger, with Olympian shareholders receiving 40,000,000 Purchaser ordinary shares valued at $10.00 per share. The transaction is subject to shareholder approvals, SEC effectiveness, and other customary closing conditions, with a termination date of June 26, 2027.

• · The Merger Agreement includes a termination date of June 26, 2027, which may be extended.
• · The Company will provide loans up to $1.6 million to the Sponsor in tranches tied to deal milestones.
• · Each Purchaser Class A ordinary share carries one vote, while each Purchaser Class B ordinary share carries ten votes and is convertible into Class A shares.
• · The board of directors of Purchaser will consist of five directors: one independent director appointed by Parent and four directors appointed by the Company.
• · The Merger Agreement may be terminated by either party if the other party causes a delay in the business combination process exceeding six months, subject to exceptions for regulatory approvals.
• · Representations and warranties of the parties will not survive the closing.

29-09-2026

Bitari Inc. has filed an S-1/A registration statement for its initial public offering. The filing warns that the company faces significant risk of failing to meet Nasdaq's new, stricter listing requirements, which include a minimum public float of $15 million and expanded discretionary denial authority. Additionally, the company will be a 'controlled company' with AI Power X Inc. holding 85.87% of shares (assuming no over-allotment exercise), giving Ms. Pei Zhao dominant voting power, and it plans to take advantage of reduced reporting obligations under the JOBS Act as an emerging growth company and smaller reporting company.

• · Bitari Inc. will rely on certain exemptions applicable to 'emerging growth company' and 'smaller reporting company' status under the JOBS Act.
• · The company has elected to use the extended transition period for complying with new or revised accounting standards.
• · Upon completion of the offering, AI Power X Inc. will hold 85.87% of the outstanding shares (no over-allotment), giving Ms. Pei Zhao dominant control.
• · Nasdaq may deny initial listing even if quantitative requirements are met, under new Rule IM-5101-3 effective December 19, 2025.
• · The company's auditors will not be required to attest to the effectiveness of internal controls over financial reporting as long as it remains a smaller reporting company.

29-09-2026

VerifyMe, Inc. is pursuing a merger with Open World Ltd., a Cayman Islands company, via a merger agreement entered on February 11, 2026. The filing provides pro forma financial information for the six months ended June 30, 2026, and includes audited financial statements of OpenWorld for 2025 and 2024. Stockholder approval was obtained on September 24, 2026, but the transaction remains subject to other closing conditions and regulatory approvals.

• · The merger agreement was entered on February 11, 2026.
• · The Registration Statement was declared effective by the SEC on August 12, 2026.
• · Stockholders approved the merger proposals on September 24, 2026.
• · The filing includes audited financial statements of OpenWorld for years ended Dec 31, 2025 and 2024, and unaudited statements for the six months ended June 30, 2026 and 2025.
• · Pro forma condensed combined financial information for VerifyMe and OpenWorld as of and for the six months ended June 30, 2026 is provided.

29-09-2026

AAR CORP. announced a definitive agreement to acquire a 65% controlling interest in MRO Holdings at an implied enterprise value of $4.0 billion, significantly enhancing its aftermarket platform scale, margins, and cash flow. The acquisition adds over $1 billion in revenue from blue-chip U.S. airline customers and is expected to expand AAR's consolidated adjusted EBITDA margins from approximately 12% to 16% before synergies, with a target of 19% to 20% within three to four years. The transaction is expected to close in AAR's fiscal third quarter ending February 2027 and will be funded through approximately $2.1 billion of new debt, $780 million of equity issued to MRO Holdings shareholders, and $230 million from a PIPE offering.

• · AAR will have the option to acquire the remaining 35% of MRO Holdings in tranches: 5% at any time within six years, and 30% in three equal 10% tranches on the second, third, and fourth anniversaries of closing.
• · AAR expects net leverage to return to its target range of 2.0x to 2.5x over the medium term.
• · AAR expects to maintain its BB-category credit rating profile at S&P and Moody's.
• · The transaction is expected to close in AAR's fiscal third quarter ending February 2027.
• · AAR will receive 100% of the excess cash flow from MRO Holdings during the first two years of ownership.
• · MRO Holdings operates facilities in El Salvador, Mexico, Colombia, and the United States.
• · Approximately 90% of MRO Holdings' revenue is from U.S. customers.
• · AAR's Board of Directors has unanimously approved the transaction.

29-09-2026

Julong Holding Ltd raised gross proceeds of US$897,750 through a private placement on September 28, 2026, issuing 750,000 Class A ordinary shares at US$0.300 per share and 2,250,000 pre-funded warrants at US$0.299 per warrant. Net proceeds after expenses are approximately US$828,000, which will be used for general corporate purposes. The filing is a routine disclosure of a capital-raising transaction and does not contain any negative or flat performance metrics.

• · The private placement is exempt from SEC registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
• · Purchasers represented they were accredited investors acquiring securities for investment only.
• · The filing incorporates by reference the company's Form F-3 registration statement (File No. 333-297664).
• · The pre-funded warrants are immediately exercisable at US$0.001 per share until exercised in full.

29-09-2026

VIP Play, Inc. filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting a net loss of $9,516 (thousand) compared to a net loss of $19,159 (thousand) in the prior year, a significant improvement. However, the company continues to operate with negative gaming margins, a deeply negative stockholders' deficit of $(39,951) (thousand), and total liabilities of $42,228 (thousand) against total assets of only $2,277 (thousand).

• · The company's accumulated deficit grew to $(72.644M) as of June 30, 2026, from $(63.128M) a year earlier.
• · Total stockholders' deficit worsened to $(39.951M) from $(31.774M).
• · Cash reserves for users dropped to zero from $277K, and players' balances also fell to zero from $336K, suggesting a cessation of user-facing operations.
• · Intangible assets were fully impaired to zero from $883K.
• · The company's line of credit from a related party increased 52.3% to $29.831M, and accrued expenses to related parties more than doubled to $5.041M.
• · Derivative liability decreased 50.5% to $5.553M, while convertible notes decreased 47.2% to $437K.
• · The company's net gaming loss increased 74.7% to $(1.041M), despite gaming revenue turning positive.
• · Sales and marketing expenses were cut by 48.2% to $590K, while general and administrative expenses rose 47.0% to $3.791M.
• · The company's dividend policy prohibits distributions if total assets would be less than total liabilities plus preferential rights.
• · Two different PCAOB-registered audit firms are listed: Frank, Rimerman + Co. LLP and Grassi & Co., CPAs, P.C.

29-09-2026

Korn Ferry held its 2026 Annual Meeting on September 24, 2026, where stockholders approved the Amended and Restated 2022 Stock Incentive Plan, increasing available shares by 1,400,000 and extending the plan term to September 24, 2036. All nine director nominees were elected, and the advisory executive compensation resolution, the Plan, and the ratification of Ernst & Young LLP as independent auditor were approved. The company also disclosed the Plan's adoption by the Board on August 4, 2026, subject to stockholder approval.

• · The Plan extends the term to September 24, 2036.
• · The Plan revises the non-employee director compensation limit to an annual cash limit instead of an annual share limit.
• · The Plan was approved by stockholders with 43,102,365 votes for, 2,155,490 against, and 24,204 abstentions.
• · The advisory executive compensation resolution received 43,800,129 votes for, 1,145,915 against, and 336,015 abstentions.
• · The ratification of Ernst & Young LLP received 46,296,359 votes for, 1,349,716 against, and 30,086 abstentions.
• · Broker non-votes were 2,394,102 for all director elections and the compensation and Plan matters.
• · The 2026 Annual Meeting was held on September 24, 2026.
• · The Board unanimously adopted the Plan on August 4, 2026, subject to stockholder approval.

29-09-2026

New Pacific Metals Corp. has announced its Annual General Meeting (AGM) will be held on November 27, 2026, in Vancouver, BC. The record date for notice, voting, and beneficial ownership determination is October 23, 2026. The filing is a routine procedural notice with no financial results or operational updates.

• · The company files under Form 40-F, not Form 20-F.
• · The meeting will be held in Vancouver, BC.
• · The issuer is not sending proxy materials directly to NOBO and is not paying for delivery to OBO.
• · Notice and Access requirements are not applicable for either beneficial or registered holders.
• · Voting security details: Common Class, CUSIP 64782A107, ISIN CA64782A1075.

29-09-2026

Quantum-Si Incorporated filed an 8-K on September 28, 2026, announcing a press release and a presentation to be delivered at World HUPO 2026 in Singapore on September 29, 2026. The presentation provides updates on the company's business and is available on the company's investor relations website. The filing is a routine Regulation FD disclosure and does not contain any financial results or material quantitative data.

• · The presentation was posted on the company's website and furnished as Exhibit 99.1 to the 8-K.
• · The press release was issued on September 28, 2026, and is included as Exhibit 99.2.
• · The presentation was scheduled for September 29, 2026 at 12:15 p.m. SGT at World HUPO 2026 in Singapore.

29-09-2026

D. Boral Acquisition I Corp. (DBCA) announced the resignation of independent director George Kollitides from the Board of Directors, effective September 23, 2026, for personal reasons. The resignation was not related to any disagreement with the company regarding its operations, policies, or practices. This is a routine board change with no financial impact.

29-09-2026

Copart Inc. filed its Form 10-K for fiscal year ended July 31, 2026, reporting total service revenues of $3,969,520 thousand, essentially flat (+0.0%) versus the prior year, while total vehicle sales grew 2.7% to $696,689 thousand. Net income margin declined slightly to 32% of revenue from 33% in 2025. The company's cash position fell sharply by 31.4% to $1,907,901 thousand, and working capital decreased 4.1%.

• · Net income margin declined to 32% of total revenue in FY2026 from 33% in FY2025, while income before income taxes remained at 40%.
• · Operating income margin remained flat at 36% of total revenue in FY2026 and FY2025.
• · Total operating expenses as a percentage of revenue remained at 64% in FY2026 and FY2025.
• · Cost of vehicle sales as a percentage of revenue remained at 13% in FY2026 and FY2025.
• · General and administrative expenses as a percentage of revenue remained at 9% in FY2026 and FY2025.
• · Income tax expense as a percentage of revenue increased to 8% in FY2026 from 7% in FY2025.